JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Search results for: '4 hqn'

Search results for: '4 hqn'

A3805 SCH772984
7 Citation

Summary: ERK1 and ERK2 inhibitor

insoluble in EtOH; insoluble in H2O; ≥14.7 mg/mL
A3248 BMS345541 hydrochloride

Target: IKK

Summary: IKK inhibitor,highly selective

insoluble in EtOH; insoluble in DMSO; ≥60 mg/mL
A8331 Bleomycin Sulfate
1 Citation

Summary: Chemotherapy agent, induces DNA strand break

≥125 mg/mL
BA7304 Gemigliptin

Summary: Gemigliptin (LC15-0444) is a highly selective, reversible, competitive inhibitor of dipeptidyl peptidase 4.
BA7305 Retagliptin

Summary: Retagliptin (SP2086) is a selective, competitive, and orally active dipeptidyl peptidase 4 inhibitor.
BA3408 GPX4-IN-3

Summary: GPX4-IN-3(26a) is a potent glutathione peroxidase 4 inhibitor that selectively induces iron death.
B1174 LGX818

Target: Raf

Summary: RAF inhibitor,potent and selective

insoluble in EtOH; insoluble in H2O; ≥13.38 mg/mL
F1936 Anti-CD3 & EpCAM Antibody (Catumaxomab (Catumaxomab (mIgG2a-rat IgG2b))

Summary: Anti-CD3 & EpCAM Antibody (Catumaxomab (Catumaxomab (mIgG2a-rat IgG2b))
F2046 Anti-VEGFR2/KDR/CD309 Antibody (Ramucirumab)

Summary: Anti-VEGFR2/KDR/CD309 Antibody (Ramucirumab)
B1404 DCC-2036 (Rebastinib)

Target: FLT3|Bcr-Abl|Tie-2|KDR

Summary: Bcr-Abl inhibitor

≥27.7 mg/mL